Centre for Primary Care & Health Services Research Seminar: ‘Risk of glucocorticoid therapy in polymyalgia rheumatica & giant cell arteritis patients with co-existing type 2 diabetes’
| Dates: | 17 November 2020 |
|---|
| Times: | 13:00 - 14:00 |
|---|
| What is it: | Seminar |
|---|
| Organiser: | Faculty of Biology, Medicine and Health |
|---|
| Who is it for: | University staff, Current University students |
|---|
| Speaker: | Dr Milica Blagojevic-Bucknall |
|---|
|
At this seminar, our guest speaker Dr Milica Blagojevic-Bucknall from Keele University will present a talk titled “Risk of glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis patients with co-existing type 2 diabetes”.
Summary
Polymyalgia rheumatica (PMR) and giant cell arteritis are both treated with glucocorticoids. Glucocorticoids exacerbate pre-existing diabetes and increases the risk of associated complications, however the impact of this has not been quantified. This study investigates the impact of glucocorticoid treatment on co-existing type 2 diabetes. GCA and PMR form two contrasting groups; one high dose group (GCA) and one medium/low dose group (PMR). The study uses Clinical Practice Research Datalink (CPRD) and we assess sensitivity to unmeasured confounding.
For Zoom details, please email: CPC.seminar.series@manchester.ac.uk
Speaker
Dr Milica Blagojevic-Bucknall
Role: Senior Lecturer in Statistics
Organisation: Keele University
Travel and Contact Information
